Clinical trial
BATTLE Program: Erlotinib in Previously Treated Subjects With Advanced NSCLC
NCT00410059
Study timeline
Study start (unknown)2006-11-01Date precision: month
Registry last updated2017-08-02
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Cancerunresolved
Interventions
ErlotinibDRUG · verified · RxNorm: erlotinib
Sponsors & collaborators
M.D. Anderson Cancer Centerlead sponsor
United States Department of Defensecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00410059 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.